StonvexLoading…
StonvexStonvexStonvexCore line items from BRTX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $359.70K | $401.00K | $145.80K | $119.80K |
Operating Income | $-15.65M | $-11.56M | $-15.22M | $-18.97M |
Net Income | $-14.24M | $-8.98M | $-10.42M | $-13.22M |
EPS (Diluted) | $-1.58 | $-1.16 | $-2.47 | $-3.65 |
Total Assets | $4.08M | $12.28M | $12.61M | $16.43M |
Total Liabilities | Not available | $3.75M | $2.61M | $6.14M |
Cash & Equivalents | $1.51M | $547.89K | $884.38K | $1.71M |
Free Cash Flow OCF − CapEx | $-10.91M | $-8.34M | $-6.60M | $-6.18M |
Shares Outstanding | 8.88M | 6.92M | 4.71M | 3.68M |